insurers glp-1 coverage news Insurance Statistics 2026 | Employer, Medicare & Medicaid Data The History Shaping the Debate

N Engl J Med 2019;381:84151.ArticlePubMed 72

Access, Cost and Shifting Landscape As people on these agents meet their weight and diabetes goals, there is concern that insurance companies will reduce or stop coverage given the high price tag of lifelong incretin therapy

These restrictions and warnings demonstrate the FDAs stringent consideration of patient safety in the drug approval process

Fatigue typically resolves as the body adjusts to appetite changes and reduced caloric intake

This plan delivers 1,400-1,600 calories daily with 100-120g protein, 25-35g fiber, and is designed to minimize side effects while maximizing nutrition